Cello Group (CLL)

 

Latest News

Cello on track

Cello Group expects results for the year ended 31 Dec to be in line with forecasts. The group said it traded well in 2017, with...

Holding(s) in Company

RNS Number: 3967X Cello Group plc 23 November 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Cello Group PLC 1...

Total Voting Rights

RNS Number: 1078V Cello Group plc 31 October 2017 Cello Group plc Total Voting Rights In conformity with the FCA's Disclosure and Transparency Rules, Cello Group plc ("Cello" or the "Company") confirms the following: As at 31 October 2017 Cello's issued share capital consists of 105,003,988 ordinary shares of 10 pence each ("Ordinary Shares"). The Company hol...

Director/PDMR Shareholding

RNS Number: 7452U Cello Group plc 26 October 2017 26 October 2017 Cello Group plc ("Cello" or the "Company") Director/PDMR Shareholding The Company has been notified that, on 26 October 2017, Alistair Shirley, a person closely associated with Jane Shirley, CEO of Cello Health Europe and Cello Health Insight, purchased 2,000 ordinary shares of 10 pence each...

All News

DateHeadlineSource
18-01-18Cello on track StockMarketWire
23-11-17Holding(s) in CompanyRNS
31-10-17Total Voting RightsRNS
26-10-17Director/PDMR ShareholdingRNS
06-10-17The companies behind AIM's incredible rallyInteractive Investor
29-09-17Grant of OptionsRNS
27-09-17Director/PDMR ShareholdingRNS
22-09-17Director Deals - Cello Group PLC (CLL)StockMarketWire
22-09-17Director Deals - Cello Group PLC (CLL)StockMarketWire
22-09-17Director Deals - Cello Group PLC (CLL)StockMarketWire
22-09-17Director Deals - Cello Group PLC (CLL)StockMarketWire
22-09-17Director Deals - Cello Group PLC (CLL)StockMarketWire
22-09-17Director Deals - Cello Group PLC (CLL)StockMarketWire
22-09-17Director/PDMR ShareholdingRNS
20-09-17Holding(s) in CompanyRNS
20-09-17Additional Block Listing of Ordinary SharesRNS
20-09-17Cello hikes divi after encouraging H1StockMarketWire
20-09-17Interim ResultsRNS
31-08-17Total Voting RightsRNS
31-07-17Total Voting RightsRNS
19-07-17Cello on track StockMarketWire
19-07-17Pre Close Trading StatementRNS
18-07-17Cello acquires Advantage HealthcareStockMarketWire
18-07-17Acquisition of Advantage Healthcare IncRNS
30-06-17Total Voting RightsRNS
23-06-17Holding(s) in CompanyRNS
14-06-17Director/PDMR ShareholdingRNS
31-05-17Total Voting RightsRNS
18-05-17Holding(s) in CompanyRNS
09-05-17Cello confident after good start StockMarketWire
09-05-17AGM StatementRNS
02-05-17Issue of EquityRNS
13-04-17Annual Report and notice of Annual General MeetingRNS
04-04-17Block listing Interim ReviewRNS
31-03-17Total Voting RightsRNS
28-03-17Holding(s) in CompanyRNS
22-03-17Broker Forecast - N+1 Singer issues a broker note on Cello Group PLCStockMarketWire
22-03-17Cello revenues rise StockMarketWire
22-03-17Preliminary ResultsRNS
21-02-17Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:CLL Editorial
  • Regulatory news feed for LSE:CLL Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account